Lourd Capital’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$921K Buy
3,344
+15
+0.5% +$3.7K 0.09% 42
2019
Q1
$744K Sell
3,329
-215
-6% -$44.4K 0.07% 47
2018
Q4
$659K Buy
3,544
+9
+0.3% +$1.84K 0.05% 91
2018
Q3
$883K Buy
+3,535
New +$858K 0.06% 75
2018
Q1
Sell
-3,530
Closed -$552K 206
2017
Q4
$552K Buy
3,530
+253
+8% +$39.8K 0.04% 143
2017
Q3
$510K Sell
3,277
-5
-0.2% -$791 0.05% 63
2017
Q2
$530K Buy
3,282
+5
+0.2% +$812 0.05% 56
2017
Q1
$507K Buy
3,277
+36
+1% +$4.96K 0.05% 56
2016
Q4
$380K Buy
3,241
+11
+0.3% +$1.25K 0.04% 61
2016
Q3
$364K Buy
3,230
+1
+0% +$105 0.04% 63
2016
Q2
$300K Hold
3,229
0.08% 82
2016
Q1
$253K Sell
3,229
-109
-3% -$7.85K 0.03% 101
2015
Q4
$243K Sell
3,338
-25
-0.7% -$1.78K 0.03% 105
2015
Q3
$250K Buy
3,363
+39
+1% +$2.79K 0.03% 94
2015
Q2
$213K Hold
3,324
0.02% 115
2015
Q1
$257K Hold
3,324
0.03% 110
2014
Q4
$246K Buy
+3,324
New +$233K 0.02% 104
2014
Q3
Sell
-3,324
Closed -$222K 115
2014
Q2
$222K Hold
3,324
0.02% 103
2014
Q1
$202K Buy
+3,324
New +$198K 0.02% 101

Other funds holding IDXX

Lourd Capital's IDXX Position: Q2 2019 in Review

Lourd Capital increased its Idexx Laboratories (IDXX) stake by 0.45% in Q2 2019, buying an estimated $3.7K and bringing the position to 3,344 shares worth $921K. The position accounts for 0.09% of the portfolio, ranked #42.

Lourd Capital first reported a position in IDXX in Q1 2014 and has held it in 19 quarters since. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2019.

  • Lourd Capital held 3,344 shares of Idexx Laboratories worth $921K as of Q2 2019.
  • Lourd Capital bought 15 Idexx Laboratories shares in Q2 2019, an estimated $3.7K.
  • Idexx Laboratories made up 0.09% of Lourd Capital's portfolio in Q2 2019, its #42 holding.
  • Lourd Capital first reported a position in Idexx Laboratories in Q1 2014 and has held it in 19 quarters since.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2019.

Based on Lourd Capital's 13F filing for Q2 2019, filed 11 Jul 2019.